Detalles de la búsqueda
1.
Efficacy of sacubitril/valsartan versus olmesartan in Japanese patients with essential hypertension: a randomized, double-blind, multicenter study.
Hypertens Res;
45(5): 824-833, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35058583
2.
Aliskiren, a novel oral renin inhibitor, provides dose-dependent efficacy and placebo-like tolerability in Japanese patients with hypertension.
Hypertens Res;
29(12): 997-1005, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17378372
3.
LCZ696, a First-in-Class Angiotensin Receptor-Neprilysin Inhibitor: The First Clinical Experience in Patients With Severe Hypertension.
J Clin Hypertens (Greenwich);
18(4): 308-14, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26402918
4.
Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction.
Hypertens Res;
38(4): 269-75, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25693859
5.
Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled study.
Hypertension;
63(4): 698-705, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24446062
6.
Long-term safety, tolerability, and antihypertensive efficacy of aliskiren, an oral direct renin inhibitor, in Japanese patients with hypertension.
Hypertens Res;
32(3): 169-75, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19262478
Resultados
1 -
6
de 6
1
Próxima >
>>